Simple. Powerful.
Biosensors for Health & Biotech
Featured News: "Biotech Startup Monod Bio Collects $25M Seed Financing"
Wall Street Journal | August 15, 2022 | Biotech Startup Monod Bio Collects $25 Million Seed Financing (wsj.com)
Management Team
01
Chief Executive Officer
Daniel-Adriano Silva, PhD
Chief Executive Officer
Daniel is a biochemist, entrepreneur, and world-renowned expert in de novo protein design. Daniel completed his undergraduate degree and Ph.D. at UNAM (Mexico), has authored multiple peer-reviewed publications in high-impact journals and is an inventor on several patents. Among his accomplishments, he was the main architect behind NL-201, the first de novo protein to reach clinical trials.
Alfredo Quijano Rubio, PhD
Chief Scientific Officer
Alfredo graduated in Bioengineering from the UW IPD under David Baker's mentorship. His research focuses on de novo protein design of conditionally-active protein systems that can address challenges in immunotherapy and diagnostics. He has authored multiple scientific publications in high-impact peer-reviewed journals and has published numerous patents describing his inventions.
02
Chief Scientific Officer
Careers
We are hiring! Please follow our job opportunities on LinkedIn and Indeed. You're also welcome to send your resume with a cover letter to us using the link below.
03
Chief Operating Officer
David Shoultz, PhD, MBA
Chief Operating Officer
David obtained his PhD in epidemiology from the University of Washington, and his MBA from the Albers School of Business & Economics at Seattle University. His background spans multiple therapeutic areas with particular expertise in infectious diseases, global health, and non-dilutive financing. He is an experienced executive leader and product developer with expertise in diagnostics, drugs, vaccines, and medical devices.
Contact Us
Fluke Hall – University of Washington
4000 Mason Road
Seattle, WA 98105
Send us your CV or resume with a cover letter.